Literature DB >> 12098026

Laparoscopic treatment of fulminant ulcerative colitis.

R L Bell1, N E Seymour.   

Abstract

BACKGROUND: The complexity and risks of the surgical treatment of ulcerative colitis are greater in patients with fulminant disease. Subtotal colectomy is frequently offered to such patients to control acute disease and restore immunological and nutritional status prior to a restorative procedure. The role of laparoscopy in this setting is poorly defined.
METHODS: The records of 18 patients with poorly controlled fulminant colitis on aggressive immunosuppressive therapy who underwent laparoscopic subtotal colectomy were reviewed.
RESULTS: Postoperative complications occurred in six patients (33%). Postoperative length of stay was 5.0 +/- 0.3 days vs 8.8 +/- 1.8 days (p<0.05) for a group of six patients who had undergone open subtotal colectomy for the same indications. Systemic steroids were withdrawn in all patients, and 17 patients subsequently underwent proctectomy and pelvic pouch construction.
CONCLUSIONS: The relatively high morbidity rate in these patients is likely related to their compromised status at the time of surgery. Laparoscopic subtotal colectomy in patients with fulminant ulcerative colitis allows for earlier hospital discharge, facilitates subsequent pelvic pouch, construction, and provides an excellent alternative to conventional two- and three-stage surgical treatment.

Entities:  

Mesh:

Year:  2002        PMID: 12098026     DOI: 10.1007/s00464-001-8300-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  15 in total

1.  Safety, feasibility, and short-term outcomes of laparoscopic ileal-pouch-anal anastomosis: a single institutional case-matched experience.

Authors:  David W Larson; Robert R Cima; Eric J Dozois; Michael Davies; Karen Piotrowicz; Sunni A Barnes; Bruce Wolff; John Pemberton
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

Review 2.  The role of laparoscopic surgery for ulcerative colitis: systematic review with meta-analysis.

Authors:  Xiao-Jian Wu; Xiao-Sheng He; Xu-Yu Zhou; Jia Ke; Ping Lan
Journal:  Int J Colorectal Dis       Date:  2010-02-17       Impact factor: 2.571

Review 3.  Surgical treatment of ulcerative colitis in the biologic therapy era.

Authors:  Alberto Biondi; Marco Zoccali; Stefano Costa; Albert Troci; Ettore Contessini-Avesani; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2012-04-28       Impact factor: 5.742

4.  Reoperation following minimally invasive surgery: are the "rules" different?

Authors:  James T McCormick; Clifford L Simmang
Journal:  Clin Colon Rectal Surg       Date:  2006-11

Review 5.  Minimally invasive approaches for the treatment of inflammatory bowel disease.

Authors:  Marco Zoccali; Alessandro Fichera
Journal:  World J Gastroenterol       Date:  2012-12-14       Impact factor: 5.742

Review 6.  Laparoscopic approach in gastrointestinal emergencies.

Authors:  Rosa M Jimenez Rodriguez; Juan José Segura-Sampedro; Mercedes Flores-Cortés; Francisco López-Bernal; Cristobalina Martín; Verónica Pino Diaz; Felipe Pareja Ciuro; Javier Padillo Ruiz
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

7.  Systematic review of emergent laparoscopic colorectal surgery for benign and malignant disease.

Authors:  Manish Chand; Muhammed R S Siddiqui; Ashish Gupta; Shahnawaz Rasheed; Paris Tekkis; Amjad Parvaiz; Alex H Mirnezami; Tahseen Qureshi
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

8.  Laparoscopy for inflammatory bowel disease: pushing the envelope.

Authors:  Peter W Marcello
Journal:  Clin Colon Rectal Surg       Date:  2006-02

9.  Surgical management of acute colitis and toxic megacolon.

Authors:  Tracey D Arnell
Journal:  Clin Colon Rectal Surg       Date:  2004-02

Review 10.  Colectomy in patients with acute colitis: a systematic review.

Authors:  P H E Teeuwen; M W J Stommel; A J A Bremers; G J van der Wilt; D J de Jong; R P Bleichrodt
Journal:  J Gastrointest Surg       Date:  2009-01-09       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.